gliclazide has been researched along with Benign Mucosal Pemphigoid in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cozzani, E | 1 |
| Di Zenzo, G | 1 |
| Cioni, M | 1 |
| Javor, S | 1 |
| Altieri, M | 1 |
| Anselmi, L | 1 |
| Parodi, A | 1 |
1 other study available for gliclazide and Benign Mucosal Pemphigoid
| Article | Year |
|---|---|
Is gliclazide a new antidiabetic drug implicated in the pathogenesis of ocular mucous membrane pemphigoid?
Topics: Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Gliclazide; Humans; Hypoglycemic Agents; Pemph | 2018 |